Subscribe to receive 91outcomes email updates

Tuesday, February 23, 2016

Statement for the Record -- Ron Brown





Thank you, Chairman Coffman, Ranking Member Kuster, and Members of
the House Veterans’ Affairs Subcommittee on Oversight and
Investigations. I thank you for holding this investigative hearing on Gulf
War health issues on the eve of the 25th anniversary of our successful
ground invasion to liberate Kuwait.

My name is Ronald Brown; I’m President of the National Gulf War
Resource Center (NGWRC). The NGWRC is a small 501 (c) (3) non-profit
veteran service organization, which is comprised of sick Persian Gulf War
veterans who volunteer our time to advocate for our fellow veterans
suffering from the complexities of modern warfare. We specialize in Gulf
War Illness claims, we work with veterans to educate and assist them in
the claims process. We also work with policy makers inside the VA, in an
attempt to accomplish two goals: first, to insure clinicians are better
trained about conditions facing this group of veterans to insure the
veterans receive the best health care possible.

Secondly, we are working to address and correct issues affecting this
group of veterans, such as the high denial rate of Gulf War illness related

We also strive to inform veterans concerning ongoing research being
conducted by both the Department of Veterans Affairs and the
Congressionally Directed Medical Research Programs (CDMRP). We strive
to get veterans involved in the research as participants.

In my view, the Congressionally Directed Medical Research Program
(CDMRP) is by far leading the way on research for our sick Gulf War
veterans. Many studies funded by the CDMRP have shown promise that
may provide insight into Gulf War illness. These studies may eventually
identify ways to diagnose and treat Gulf War Illness. Additional follow-up
(replication on a larger scale) is needed on these promising pilot studies.
Unfortunately, in our view, the VA Office of Research and Development
(ORD) have been slow to replicate any of these promising pilot studies.
Until this is done, these studies will not benefit veterans by providing
effective treatments or new presumptive conditions for benefits.

Recently, I attended the public briefing for The Gulf War and Health,
Volume 10: Update of Health Effects of Serving in the Gulf War. While I
agree with the committee’s recommendation to use the term Gulf War
Illness (GWI), overall I was shocked and troubled by the conclusions and
recommendations this committee reached.

This committee suggest that the "conditions associated with Gulf War
deployment are primarily mental health disorders and functional medical
disorders and that these associations emphasize the interconnectedness
of the brain and body (page 11, IOM vol 10).” This committee also stated
“Veterans who were deployed to the Gulf War do not appear to have an
increased risk for many long term health conditions with the exceptions
of Post-Traumatic Stress Disorder (PTSD), Gulf War Illness (GWI), Chronic
Fatigue Syndrome (CFS), Functional Gastrointestinal conditions,
generalized anxiety disorder, depression and substance abuse.”

The committee added further insult to sick Desert Storm veterans
when they recommended: “Further studies to assess the increased
incidence and prevalence of circulatory, hematologic, musculoskeletal,
gastrointestinal, genitourinary, reproductive, endocrine and metabolic,
respiratory, chronic skin, and mental health conditions due to
deployment in the Gulf War should not be undertaken. Rather, future
research related to these conditions should focus on ensuring that Gulf
War veterans receive timely and effective treatment (page 9, IOM vol
10).” This committee recommended that future research should focus on
treating and managing Gulf War illness rather than its causes.

I agree treatments and managing Gulf War illness is important;
however, I also believe that we should understand the causes of this
illness in Desert Storm veterans if we are to prevent toxic illness and
injury to future generations of our Armed forces. This committee
recommended individual and environmental biomonitoring during future
conflicts. I agree with this recommendation with skepticism based on
DOD’s history of reluctance to release information concerning exposures
during Desert Storm.

I strongly disagree with this committee’s recommendation that
“further studies to assess the increased incidence and prevalence of
health conditions due to deployment in the Gulf War should not be
undertaken.” If this committee has their way, I’m afraid we never will
learn what caused our illness, how to treat ill Persian Gulf Veterans, and
we will never have the evidence to warrant adding new presumptive

Since 2002, sick Desert Storm veterans who have attended, or listen in
by phone, to the Research Advisory Committee (RAC) meetings have
listened to presentations that show VA epidemiological studies have
shown that deployed Desert Storm veterans have higher prevalence of:

 Migraine headaches (20.3% deployed vs 16.1% non-deployed).
 Chronic obstructive pulmonary disease (8.4% deployed vs 6.3%
 Dermatitis (27.4% deployed vs 21.1% non-deployed).
 Functional dyspepsia (27.7% deployed vs 15.9% non-deployed).
 Tachycardia (8.1% deployed vs 5.9% non-deployed).
 Irritable bowel syndrome (24.4% deployed vs 14.3% non deployed).

Yet, the IOM committee puts many of these issues listed above in its
Inadequate/Insufficient Evidence to Determine Whether an Association
Exist category.

There is most definitely a problem with this committee’s report as the
VA’s own research shows one thing, and the IOM committee is saying
something completely different. This report is an injustice to sick Desert
Storm veterans. This report winds the clock backwards to the 1994
mindset. In 1994 the VA as well as the Department of Defense (DOD) said
that GWI was nothing more than combat stress, PTSD, or psychological
illnesses. Desert Storm veterans thought we had escaped the “it’s all in
your head” mindset with the ground breaking 2008 Research Advisory
Committee report. Yet here we are twenty-five years after the war, and
sick Desert Storm veterans are still waiting for treatments, many are still
waiting on service connection for presumptive conditions per current law,
and we still wait and hope new presumptive conditions will be added.

My reasoning for my belief that there is a problem with this
committee’s report is during the briefing when I asked why studies that
showed cancer at higher rates weren’t considered by this committee,
URMC Professor Deborah Cory-Slechta referenced the 2004 GOA report
that stated the Khamisiyah plume model was flawed that was used in
VA’s research. This same GOA report also stated that the VA and DOD’s
hospital rate study was also flawed, yet this committee still used this
study to reach their conclusions (page 200, IOM vol 10).

This IOM committee retrieved over 280 studies of potential relevance
to this report. 204 studies that “did not appear to have immediate
relevance, based on an assessment of the title and abstract” were deleted
without consideration leaving only 76 potential relevant studies
considered and discussed by this committee (page 25, IOM vol 10).

Nowhere in this report are these 204 deleted studies listed. My question
is how many of these deleted studies were VA and CDMRP studies? An
additional 100 papers dealing with animal models were reviewed and half
were deleted for further consideration (page 26, IOM vol 10). Of the half
that was not considered, how many were VA and CDMRP papers?
The NGWRC honestly feels this report is flawed. We are grateful that
the House Veterans’ Affairs Subcommittee on Oversite and Investigation
has decided to investigate this matter.

(1). Ensure any future contract between the VA and IOM is made public
for Desert Storm veterans. This would ensure transparency.
(2). To further ensure transparency Veterans Service Organizations (VSO)
should be invited to the IOM’s briefing to the Department of Veterans
(3). Veterans Service Organizations should receive a copy of future IOM
reports prior to the public briefing. This will allow the VSOs to form
reasonable questions for the committee.
(4). Ensure the IOM committee list all studies they deem not relevant in
its report. A reasonable explanation as to why the study was found
irrelevant should be provided. This would ensure researchers knowledge
of the IOM’s definition of “immediate relevance”.
(5). Desert Storm veterans and our researchers need help in regards to
replication on a larger scale of studies that have shown promise.

Unfortunately, the VA Office of Research and Development (ORD) have
been slow to replicate any of these promising pilot studies. If the VA is
unable to replicate this amazing and promising research, then perhaps
increased funding should be provided to the CDMRP to replicate these
promising studies on a larger scale. Until this is done, these small
promising pilot studies will not benefit veterans by providing effective
treatments or new presumptive conditions for benefits.

Ronald E. Brown
National Gulf War Resource Center


KAT said...

Sounds like the committee members are instructed to obstruct care of Veterans! #GWI #GWS #SqualeneInVaccines!

KAT said...

Sounds like the committee members are instructed to obstruct care of Veterans! #GWI #GWS #SqualeneInVaccines! Need a #CourtOrder & #ClassActionLawSuit to be tested for #AntiSqualeneAntibodies which HAS been PROVEN to cause #ALS #MS #LUPUS #AUTOIMMUNEDISEASES #TULANEUNIVERSITYRESEARCH2007

Unknown said...

Thank you Ron and the NGWRC for all you do to help the Gulf War Veterans.
God Bless you and Jim Bunker